Pharmacodynamics of investigational pre-beta HDL-mimicking agent

3' education - May 24, 2015 - ISA2015, Amsterdam - Eralp Bellibas

Dr. Eralp Bellibas (The Medicines Company, Parsippany, NJ, USA)
Recorded at ISA2015, Amsterdam, The Netherlands on May 24-26, 2015

ISA2015 | Clinical Breakthroughs Dr. Eralp Bellibas shares pharmacokinetic and pharmacodynamic data of the apoA1-Milano-POPC (MDCO216) that was developed to mimic pre-beta HDL molecules, which was more potent at increasing cholesterol efflux in CAD patients than in healthy volunteers.